Covered recipient · General Payments record
KIMBERLY DEAN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,643.30
- Reported across 79 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $371.91 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $141.68 | 7 |
| Lilly USA, LLC | $50.85 | 3 |
| GlaxoSmithKline, LLC. | $49.93 | 2 |
| Astellas Pharma US Inc | $29.76 | 1 |
| Axonics Modulation Technologies, Inc. | $29.34 | 1 |
| Novo Nordisk AS | $24.49 | 1 |
| ViiV Healthcare Company | $23.42 | 1 |
| Abbott Laboratories | $22.44 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $22.44 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124894290 | CMS |
| ABBVIE INC. | $20.94 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103615642 | CMS |
| ABBVIE INC. | $19.65 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103615644 | CMS |
| ABBVIE INC. | $15.90 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103615646 | CMS |
| ABBVIE INC. | $14.96 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103615648 | CMS |
| ABBVIE INC. | $16.88 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103615650 | CMS |
| ABBVIE INC. | $31.68 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103615652 | CMS |
| ABBVIE INC. | $21.67 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103615654 | CMS |
| Astellas Pharma US Inc | $29.76 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139285192 | CMS |
| Axonics, Inc. | $29.34 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142387690 | CMS |
| GlaxoSmithKline, LLC. | $23.27 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116635200 | CMS |
| GlaxoSmithKline, LLC. | $26.66 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116426781 | CMS |
| Lilly USA, LLC | $20.59 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135114624 | CMS |
| Lilly USA, LLC | $15.13 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135107555 | CMS |
| Lilly USA, LLC | $15.13 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135107557 | CMS |
| Novo Nordisk Inc | $24.49 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096891363 | CMS |
| ViiV Healthcare Company | $23.42 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112774488 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.